Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analge… Read more
Sakar Healthcare Limited (SAKAR) - Total Liabilities
Latest total liabilities as of September 2025: ₹1.45 Billion INR
Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) has total liabilities worth ₹1.45 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sakar Healthcare Limited - Total Liabilities Trend (2010–2025)
This chart illustrates how Sakar Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sakar Healthcare Limited Competitors by Total Liabilities
The table below lists competitors of Sakar Healthcare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Casing Macron Technology Co Ltd
TWO:3325
|
Taiwan | NT$956.96 Million |
|
OnMobile Global Limited
NSE:ONMOBILE
|
India | ₹3.34 Billion |
|
Elementos Limited
F:9EM
|
Germany | €1.98 Million |
|
Risk George Inds A
PINK:RSKIA
|
USA | $7.94 Million |
|
JCH Systems Inc
KQ:033320
|
Korea | ₩42.00 Billion |
|
PT Eagle High Plantations Tbk
F:7B7
|
Germany | €7.01 Trillion |
|
RATH Aktiengesellschaft
VI:RAT
|
Austria | €70.66 Million |
|
PharmaCorp Rx Inc.
V:PCRX
|
Canada | CA$9.50 Million |
Liability Composition Analysis (2010–2025)
This chart breaks down Sakar Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.00 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sakar Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sakar Healthcare Limited (2010–2025)
The table below shows the annual total liabilities of Sakar Healthcare Limited from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹1.30 Billion | +2.74% |
| 2024-03-31 | ₹1.26 Billion | -22.49% |
| 2023-03-31 | ₹1.63 Billion | +16.17% |
| 2022-03-31 | ₹1.40 Billion | +76.83% |
| 2021-03-31 | ₹793.40 Million | +134.71% |
| 2020-03-31 | ₹338.04 Million | +25.29% |
| 2019-03-31 | ₹269.81 Million | -8.87% |
| 2018-03-31 | ₹296.07 Million | -15.61% |
| 2017-03-31 | ₹350.84 Million | +9.89% |
| 2016-03-31 | ₹319.27 Million | -9.68% |
| 2015-03-31 | ₹353.47 Million | -8.11% |
| 2014-03-31 | ₹384.65 Million | +1.29% |
| 2013-03-31 | ₹379.74 Million | +5.01% |
| 2012-03-31 | ₹361.61 Million | +1.54% |
| 2011-03-31 | ₹356.14 Million | +9.98% |
| 2010-03-31 | ₹323.82 Million | -- |